⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11989375 | 1.00 | — | — | |
| SCHEMBL2405453 | 1.00 | — | — | |
| SCHEMBL1367536 | 0.92 | — | — | |
| SCHEMBL15184925 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL28852943 | 0.89 | — | — | |
| SCHEMBL30277117 | 0.78 | — | — | |
| SCHEMBL26170815 | 0.71 | GAA (0.35) | — | |
| SCHEMBL254419 | 0.69 | — | — | |
| SCHEMBL9501843 | 0.69 | — | — | |
| SCHEMBL292798 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113493628-B | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116179286-A | Hydroxylamine-free water-based cleaning agent | 湖北兴福电子材料股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| US-20140249143-A1 | Compounds And Methods For Enhancing Innate Immune Responses | GLAXOSMITHKLINE LLC (US) | 2014-09-04 | — | — | US | claimed |
| EP-2768506-A2 | COMPOUNDS AND METHODS FOR ENHANCING INNATE IMMUNE RESPONSES | GlaxoSmithKline LLC (US) | 2014-08-27 | — | — | EP | claimed |
| CN-103957910-A | Compounds and methods for enhancing innate immune responses | GLAXOSMITHKLINE LLC | 2014-07-30 | — | — | CN | claimed |
| WO-2013059559-A2 | COMPOUNDS AND METHODS FOR ENHANCING INNATE IMMUNE RESPONSES | GLAXOSMITHKLINE LLC (US) | 2013-04-25 | — | — | WO | claimed |
| WO-2002028829-A2 | PEPTIDE DEFORMYLASE INHIBITORS | QUESTCOR PHARMACEUTICALS, INC. (US) | 2002-04-11 | — | — | WO | claimed |
| US-20260109715-A1 | IMIDAZOPYRIDINE DERIVATIVES WITH BICYCLIC STRUCTURE | PUBLIC UNIVERSITY CORPORATION YOKOHAMA CITY UNIVERSITY (JP) | 2026-04-23 | — | — | US | disclosed |
| CN-119410418-A | Cleaning solution for removing residues after polyimide etching | 湖北兴福电子材料股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-113493628-B | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-116179286-A | Hydroxylamine-free water-based cleaning agent | 湖北兴福电子材料股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-20170266197-A1 | METHODS AND COMPOSITIONS FOR TREATING HEPATITIS B VIRUS INFECTIONS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-09-21 | — | — | US | disclosed |
| US-20170145012-A1 | PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS | FORMA THERAPEUTICS, INC. | 2017-05-25 | — | — | US | disclosed |
| US-8338460-B2 | 3-({4-[2-(dimethylamino)ethoxy]phenyl}thio)-N-(3-methyl-1,2,4-thiadiazol-5-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)thio]pyridine-2-carboxamide; glucokinase activator; antidiabetic, obesity | MSD K. K. (JP) | 2012-12-25 | — | — | US | disclosed |
| EP-2077266-B1 | 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY | MSD KK (JP) | 2012-07-25 | — | — | EP | disclosed |
| EP-2077266-A1 | 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2009-07-08 | — | — | EP | disclosed |
| US-20080090799-A1 | 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING EFFECT | MSD K.K. (JP) | 2008-04-17 | — | — | US | disclosed |
| EP-1371645-A1 | Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments | Noe, Christian R. (AT) | 2003-12-17 | — | — | EP | disclosed |
| EP-1369414-A1 | Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors | Noe, Christian R. (AT) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002028829-A2 | PEPTIDE DEFORMYLASE INHIBITORS | QUESTCOR PHARMACEUTICALS, INC. (US) | 2002-04-11 | — | — | WO | disclosed |